SCHEMBL8744064

SCHEMBL8744064

C=CCS(=O)(=O)C(=O)c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKT1 P31749 1/20 0.45
ALDH1A1 P00352 5/20 0.41
HPGD P15428 2/20 0.41
LMNA P02545 1/20 0.41
CES1 P23141 3/20 0.39
MAPK1 P28482 3/20 0.39
TDP1 Q9NUW8 2/20 0.39
KDM4E B2RXH2 2/20 0.39
MAPT P10636 2/20 0.39
MEN1 O00255 1/20 0.39
CYP3A4 P08684 1/20 0.39
ALOX15 P16050 1/20 0.39
KMT2A Q03164 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
POLB P06746 1/20 0.38
TSHR P16473 3/20 0.38
CES2 O00748 2/20 0.38
DAO P14920 1/20 0.38
NAPRT Q6XQN6 1/20 0.38
CYP2C19 P33261 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3626577 0.81 ALDH1A1 (0.42) ALDH1A1HPGDLMNACES1TDP1
SCHEMBL11884763 0.75 ALDH1A1 (0.40) AKT1ALDH1A1HPGDLMNACES1
SCHEMBL11884753 0.75 ALDH1A1 (0.40) AKT1ALDH1A1HPGDLMNACES1
SCHEMBL27722919 0.74 RECQL (0.46) AKT1ALDH1A1HPGDLMNACES1
SCHEMBL6393324 0.73 LMNA (0.49) AKT1ALDH1A1HPGDLMNAMAPT
SCHEMBL6393316 0.73 AKT1 (0.41) AKT1ALDH1A1HPGDLMNACES1
SCHEMBL6157296 0.73 LMNA (0.44) AKT1ALDH1A1HPGDLMNAMAPK1
SCHEMBL5610425 0.72 TSHR (0.50) HPGDCES1MAPK1TDP1KDM4E
SCHEMBL11884770 0.72 ALDH1A1 (0.37) ALDH1A1LMNAMAPTMEN1CYP3A4
SCHEMBL1782352 0.72 ALDH1A1 (0.49) ALDH1A1LMNAMAPK1TDP1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0246534-B1 Optically pure 4,5-disubstituted gamma-butyrolactame enantiomers, process for their preparation and their use BAYER AG (DE) 1997-01-15 EP claimed
EP-0246534-B1 Optically pure 4,5-disubstituted gamma-butyrolactame enantiomers, process for their preparation and their use BAYER AG (DE) 1997-01-15 EP disclosed
EP-0246534-A2 Optically pure 4,5-disubstituted gamma-butyrolactame enantiomers, process for their preparation and their use BAYER AG (DE) 1987-11-25 EP disclosed